Terms of Use

All Content on this Site, including but not limited to the Treatment Database, Biomarker Explorer, Glossary, and Resource Directory, is the original intellectual property of Nita Jain and is protected under United States copyright law.

This includes:

• The selection, organization, and arrangement of entries
• Evidence tier classifications and methodology
• Mechanism and pathway annotations
• Dosing ranges, side effect profiles, and clinical commentary compiled herein
• All written descriptions, labels, and structural frameworks

© 2026 Nita Jain. All rights reserved.

You may access and use the Site for the following purposes:

• Personal reference — individual patients, caregivers, and clinicians may consult the Content for informational and educational purposes
• Non-commercial research — academic researchers and students may reference the Content with appropriate attribution
• Clinical reference — licensed healthcare providers may use the Content to inform their own independent clinical judgment, provided it is not reproduced or redistributed

The following uses are explicitly prohibited without prior written permission from Nita Jain:

• Commercial reproduction — copying, extracting, or incorporating any portion of the Content into a commercial product, service, platform, application, or database
• Redistribution — republishing, sharing, or distributing the Content in any form, in whole or in part, without attribution and written authorization
• Derivative commercial works — using the Content as the basis or reference for building a competing or complementary commercial tool, platform, or database
• Scraping and automated extraction — using bots, scrapers, or automated tools to extract Content from the Site
• Removal of attribution — reproducing any Content without clearly crediting The Spooniverse and Nita Jain as the source

Any commercial use of the Content without a written licensing agreement with Nita Jain constitutes copyright infringement and may result in legal action.

Any permitted non-commercial use of Content from this Site must include the following attribution:

Source: The Spooniverse, a community project by Nita Jain

The Content on this Site is provided for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. The Treatment Database, Biomarker Explorer, Glossary, and Spooniverse Directory are reference tools intended to support informed conversations between patients and their healthcare providers.

Always consult a qualified healthcare professional before making any medical decisions. Nita Jain expressly disclaims any liability for clinical decisions made in reliance on the Content of this Site.

The Spooniverse Directory and other areas of the Site may contain links to external websites and resources. These links are provided for convenience and informational purposes only. Nita Jain does not endorse, control, or assume responsibility for the content, accuracy, or availability of any third-party sites. Accessing third-party links is at your own risk.

To the fullest extent permitted by applicable law, Nita Jain shall not be liable for any direct, indirect, incidental, consequential, or punitive damages arising from your use of or reliance on the Site or its Content.

The Content is provided “as is” without warranties of any kind, express or implied, including but not limited to warranties of accuracy, completeness, fitness for a particular purpose, or non-infringement. Nita Jain makes no guarantee that the Content is current, error-free, or suitable for any specific clinical or research application.

These Terms of Use shall be governed by and construed in accordance with the laws of the State of Georgia, without regard to its conflict of law provisions. Any disputes arising under these Terms shall be subject to the exclusive jurisdiction of the courts located in Georgia.

Nita Jain reserves the right to modify these Terms of Use at any time. Changes will be posted on this page with an updated effective date. Continued use of the Site following any changes constitutes acceptance of the revised Terms.